Analysts Viewpoint
Understanding the Risks of Investing in Neogenomics Inc (NEO)
Neogenomics Inc’s filing revealed that its Director Kelly Michael Aaron acquired Company’s shares for reported $38000.0 on May 27 ’25.
Menu
Neogenomics Inc’s filing revealed that its Director Kelly Michael Aaron acquired Company’s shares for reported $38000.0 on May 27 ’25.
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Neogenomics Inc’s recently made public that its Director Kelly Michael Aaron acquired Company’s shares for reported $38000.0 on May 27
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Neogenomics Inc’s recently made public that its Director Kelly Michael Aaron acquired Company’s shares for reported $38000.0 on May 27
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Neogenomics Inc’s filing revealed that its Director Kelly Michael Aaron acquired Company’s shares for reported $38000.0 on May 27 ’25.
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Neogenomics Inc’s filing revealed that its Director Kelly Michael Aaron acquired Company’s shares for reported $38000.0 on May 27 ’25.